D. J. Khalaf, “A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate”, CUAJ, vol. 12, no. 2, pp. E47–52, Dec. 2017.